Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.
about
DIPG in Children - What Can We Learn from the Past?Children's Oncology Group's 2013 blueprint for research: radiation oncologyAdvances in the management of paediatric high-grade glioma.Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data.Challenges of Treating Childhood Medulloblastoma in a Country With Limited Resources: 20 Years of Experience at a Single Tertiary Center in MalaysiaComparison of survival between the UK and US after surgery for most common pediatric CNS tumors.Management of diffuse pontine gliomas in children: recent developments.Overcoming multiple drug resistance mechanisms in medulloblastoma.Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas.Histology predicts a favorable outcome in young children with desmoplastic medulloblastoma: a report from the children's oncology group.Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors.Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.Late effects in survivors of childhood CNS tumors treated on Head Start I and II protocols.Institutional experience of paediatric high-grade central nervous system tumours: an analysis of 74 patients and review of the literature.Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34.Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma.Factors affecting survival of medulloblastoma in children: the changing concept of management.Expression patterns and potential roles of SIRT1 in human medulloblastoma cells in vivo and in vitro.High-grade glioma in very young children: a rare and particular patient population.Treatment of children with diffuse intrinsic pontine gliomas with chemoradiotherapy followed by a combination of temozolomide, irinotecan, and bevacizumab.Desmoplastic Nodular Medulloblastoma in Young Children: A Management Dilemma.Pediatric central nervous system tumors in the first 3 years of life: pre-operative mean platelet volume, neutrophil/lymphocyte count ratio, and white blood cell count correlate with the presence of a central nervous system tumor.Applying the International Classification of Functioning-Children and Youth Version to Pediatric Neuro-oncology.The role of chemotherapy and surgical removal in the treatment of Choroid Plexus carcinomas and atypical papillomas.Choroid plexus carcinoma in children: the Head Start experience.Genetic Analysis of Diffuse High-Grade Astrocytomas in Infancy Defines a Novel Molecular Entity.Therapeutic implications of CD1d expression and tumor-infiltrating macrophages in pediatric medulloblastomas.A deregulated integrated stress response promotes interferon-γ-induced medulloblastoma.ANZCCSG BabyBrain99; intensified systemic chemotherapy, second look surgery and involved field radiation in young children with central nervous system malignancy.
P2860
Q26777843-20B0FE67-C6A1-47F9-97A2-96611EE7D7CCQ27023346-8D826A90-4377-4E7C-9058-5EC01B5501E3Q30870633-171C15D6-1A7D-4FE1-AB7D-B6D98A899270Q31151075-717E4B18-2B9C-4024-A06A-CD185948035DQ33859754-E274B0EB-2BE4-4580-B865-854E144D5531Q33894483-28AD98A3-50BA-4474-B8C5-28FD818CEA8BQ34347540-738F5F77-AFB2-4B5D-84C5-0C056E1E6BD7Q34500602-65861F6D-931D-4BDB-892C-5FFB68CA4ACAQ34722504-DA59A508-61A1-4FF4-8505-53555CD1CB12Q35058988-4A17DFD2-7CF8-4C5D-B9AC-45FB6A41DA5AQ35602796-A6D15667-12D0-466D-8D78-9A13E155C75AQ35754390-04581CF6-A3AC-4DD1-A5A7-92C50C2D7D99Q36467511-327DAF9B-5BB0-47F4-8C71-EFE97293CA2AQ36942465-6B076B34-5B69-4BDB-822D-7CDBF0F9A1CBQ37580472-80E55054-C198-4346-89BB-D9CF13888360Q37736273-6A380DF6-301B-4B35-8B24-590E858A30F2Q38583250-8AA12C77-DC6F-4618-B107-E89DE44F753BQ39358162-32860B4E-FAC0-4862-B037-E2F329D1D0F6Q42362800-55184B37-5A34-4EC0-8319-29D5311A660AQ46897880-AB9E5CC3-0BB7-489F-9AC5-6EB1C7DAAE8DQ47284266-2775B0C6-91E7-4752-A712-257841A42A42Q47609590-59D3771C-A580-4AB6-8282-48D2BF9287FBQ47970128-4CD4C711-98A4-44EB-A07F-846D385B26B4Q48234843-3C39B689-F11F-40E8-9296-7EC1A8D91201Q48338460-AFC3BDD7-0959-471C-9324-DD8D78C48E75Q48535132-E3C0A74D-F445-42A3-B4AC-E70A38A6D160Q48608874-82791A16-BF07-4D49-AD15-CDCE9A4E89C8Q54580307-B6F108DD-73C4-4878-88B4-F70AA073F1BBQ55463436-9EC513A7-1886-42B4-B733-C9182201C939
P2860
Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Primary postoperative chemothe ...... st UKCCSG/SIOP CNS 9204 trial.
@en
Primary postoperative chemothe ...... st UKCCSG/SIOP CNS 9204 trial.
@nl
type
label
Primary postoperative chemothe ...... st UKCCSG/SIOP CNS 9204 trial.
@en
Primary postoperative chemothe ...... st UKCCSG/SIOP CNS 9204 trial.
@nl
prefLabel
Primary postoperative chemothe ...... st UKCCSG/SIOP CNS 9204 trial.
@en
Primary postoperative chemothe ...... st UKCCSG/SIOP CNS 9204 trial.
@nl
P2093
P1476
Primary postoperative chemothe ...... st UKCCSG/SIOP CNS 9204 trial.
@en
P2093
A Michalski
C C Bailey
Children's Cancer and Leukaemia Group (formerly UKCCSG) Brain Tumour Committee
D A Walker
D W Ellison
K J Robinson
P304
P356
10.1016/J.EJCA.2009.09.013
P577
2010-01-01T00:00:00Z